On this page you can find a summary of the last news and researches from scientist publications sources. Most of these reasearches are pre-clinical conclusions on small groups of people or observations on animals, this article or our products are absolutely not intended to diagnose, treat, cure or prevent any disease. Consult your professional healthcare for any specific condition.

Woher kommen Cannabidiol und Tetrahydrocannabinol?

Da die legale Verwendung von medizinischem Marihuana und vielen Cannabisprodukten immer häufiger wird, werden die Verbraucher immer neugieriger auf ihre Wirksamkeit für die Behandlung verschiedener Erkrankungen. Cannabis-Produkte umfassen sowohl Cannabidiol, oder CBD,und Tetrahydrocannabinol, oder THC. Diese beiden natürlichen Verbindungen sind in Pflanzen der Cannabis-Gattung gefunden.

CBD wird sowohl aus Marihuana- als auch aus Hanfpflanzen extrahiert, jedoch variiert der THC-Gehalt in beiden Pflanzen. THC ist in sehr Spurenmengen im< Hanf ( 0,3) vorhanden, aber es ist in höheren Konzentrationen in Marihuana vorhanden. Im Vergleich zu THC, das Ihnen das „hohe“ Gefühl gibt, enthält CBD keine der psychoaktiven Eigenschaften von THC.

Wie funktioniert CBD und THC ?

Beide Verbindungen interagieren hauptsächlich mit dem Endocannabinoid-System, das hauptsächlich zwei Arten von Rezeptoren umfasst: Cannabinoid-Rezeptoren Typ1 (CB-1) und Typ 2 (CB-2). Cannabinoide Rezeptoren Typ 1 sind im Gehirn dominanter, während CB-2 in der Peripherie, insbesondere im Immunsystem, vorherrschender sind. Das Endocannabinoid-System (ECS) kann eine Vielzahl von physiologischen Prozessen beeinflussen, einschließlich Appetit, Stimmung, Gedächtnis, Schmerzempfindung, und immunologische Prozesse. Durch diesen Mechanismus, Cannabinoide Verbindungen, einschließlich CBD und THC können ihre therapeutische Wirkung zeigen.

Gewinne Preise, indem du an unseren Wettbewerben teilnimmst!

Geben Sie Ihre E-Mail-Adresse ein, um an unserem nächsten Wettbewerb teilzunehmen und viele Geschenke zu gewinnen! Jeden Monat veranstalten wir einen kostenlosen Wettbewerb mit Produkten, um zu gewinnen. CBD-Öl, Süßigkeiten, Kapseln, Aufguss ... Verpassen Sie diese Gelegenheit nicht !

Wir versenden niemals Spam in Übereinstimmung mit unseren Datenschutzrichtlinien.

What Are the Similarities Between CBD and THC ?

Both Cannabidiol and Delta-9 Tetrahydrocannabinol have the same molecular and chemical structure, and both are similar to the body’s own endocannabinoids. This is how both compounds interact with their designated receptors within the brain and in the immune system. Even more, both compounds have been shown to elicit the same effects on the targeted structure, as both have been shown to alleviate pain, treat nausea and vomiting, manage convulsions and seizure, and minimize the inflammatory process in many medical conditions.

What Are the Differences Between CBD and THC ?

Despite the similarities in their chemical structures, Cannabidiol and THC don’t have the same psychoactive properties. In fact, CBD is a non-psychoactive compound. This means that CBD doesn’t produce the “high” associated with THC.

THC binds with cannabinoid receptors type 1 in the brain, and that’s why it produces a ‘high’ sense or a sense of euphoria and ultimate happiness. On the other hand, CBD has a low potency to bind with CB1 receptors. Even more, CBD can interfere with the binding of THC to CB1 receptors and therefore reduces its psychoactive effects.

Is CBD superior to THC ?

Yes, the number of therapeutic effects of CBD and the number of medical conditions it treats are far more frequent than what THC has. According to the World Health Organization (WHO), CBD exhibits no properties indicative of any abuse or dependence potential in human. To date, there is no substantial evidence reporting any health-related problems associated with the use of high concentrations of CBD.

Moreover, the International Cannabinoid Research Society (ICRS) has highlighted a wide range of molecular pathways through which CBD can exhibit various therapeutic properties in the treatment of many medical illnesses. In addition to that, the Food and Drug Administration (FDA) in June 2018 has approved the use of Epidiolex, the first medication to contain CBD, in the treatment of definite forms of epilepsy.

CBD has been also shown to possess potent analgesic, antiemetic, antioxidant, antipsychotic, anti-spasmodic, and neuroprotective properties, especially in the treatment of depression. Furthermore, CBD has been reported to have very minimal side effects, if any. However, the results of the current research are not evident or substantial. Therefore, more research on humans is warranted to be able to prescribe CBD for the general population during the treatment process of various diseases.

What Are the Therapeutic Potentials of both CBD and THC ?

Cannabinoids, including both CBD and THC, have the potential to be ideal therapeutic options in treating various inflammatory neuropathies, as they can readily penetrate the blood-brain barrier (BBB), which inhibits various toxic substances from entering the brain. Through this mechanism, CBD and THC can access the brain, have low levels of toxicity, and exert their effects directly through the cannabinoid receptors.

CBD is being thoroughly investigated as preliminary studies have shown that it has various potential therapeutic properties in treating and managing the following medical conditions: 

  • Epilepsy and Seizures.
  • Inflammatory processes, including Ulcerative Colitis (UC), Crohn’s disease, Rheumatoid Arthritis (RA), and Osteoarthritis.
  • Pain.
  • Psychosis and mental disorders, particularly Depression.
  • Nausea and Vomiting.
  • Headaches and Migraines.
  • Anxiety.
  • Acne.

On the other hand, THC has been shown to have the following potentially promising effects:

  • Pain.
  • Muscle spasticity and rigidity.
  • Insomnia.
  • Decreased appetite.
  • Nausea and Vomiting.
  • Anxiety.

Herein, we summarize the various potential effects of both CBD and THC studies in the medical literature as reported by preliminary human and animal studies.

 

Therapeutic UsesCannabidiol (CBD)Delta-9 Tetrahydrocannabinol (THC)
AnalgesicYesYes
AntibacterialYesNo
Anti-diabeticYesNo
Anti-emeticYesYes
Anti-epilepticYesNo
Anti-inflammatoryYesYes
Anti-insomniaYesNo
Anti-ischemic (treats atherosclerosis)YesNo
Anti-AcneYesNo
Anti-psoriasisYesNo
AntipsychoticYesNo
AnxiolyticYesNo
Treats Anorexia nervosa/ Stimulates AppetiteYesYes
ImmunosuppressiveYesNo
NeuroprotectiveYesNo